A size-switchable microsphere loaded with salmon calcitonin as two-weekly dosing for osteoporosis therapy
European Journal of Pharmaceutics and Biopharmaceutics · 2024-12 · 205 · 114565
DOI: 10.1016/j.ejpb.2024.114565 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024-12. Verfasst von Xueyan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, PR China. Hauptthemen laut MEDLINE: Microspheres, Osteoporosis, Calcitonin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Osteoporosis is a disease with an increased incidence of fractures due to decreased bone mass and destruction of the microstructure of bone tissue. Salmon calcitonin (sCT), as a peptide, possesses the ability to inhibit osteoclast activity and thus regulate bone metabolism in clinical. However, short half-life and unstable physicochemical properties leading to rapid degradation of sCT have severely limited its clinical application. In this study, a size-switchable microsphere was developed to solve the problem of frequent administration and poor stability of sCT. sCT was encapsulated into Egg PC to form anhydrous reverse micelles (ARM) and then ARM was encapsulated into microspheres (MS@ARM). The degradable composite microspheres were utilized to provide a drug reservoir for sustained release of ARM encapsulated with sCT to reduce the frequency of drug administration, while the released ARM encapsulated with sCT entered the blood circulation to further protect sCT. In vitro release experiments demonstrated that the microspheres could sustain the release of sCT for at least 16 days. The microspheres MS@ARM showed the advanced therapeutic effect on the mouse model of glucocorticoid-induced osteoporosis (GIOP) at a low dosing frequency. The size-switchable microsphere is expected to be a new strategy for delivering sCT for osteoporosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, PR China.
- Department of Neurology, The Second Hospital of Jilin University, Changchun 130041, PR China.
- School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, PR China. Electronic address: jieyang@jlu.edu.cn.
- Practice Training Center, Changchun University of Chinese Medicine, Changchun 130117, PR China. Electronic address: biye88@outlook.com.
- School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, PR China. Electronic address: tenglesheng@jlu.edu.cn.
Zitieren
APA
Zhang, X., Chen, J., Cui, Y., Cui, Y., Yan, G., Tang, H., Man, Y., Yang, J., Bi, Y., & Teng, L. (2024). A size-switchable microsphere loaded with salmon calcitonin as two-weekly dosing for osteoporosis therapy. European Journal of Pharmaceutics and Biopharmaceutics, 205, 114565. https://doi.org/10.1016/j.ejpb.2024.114565
Vancouver
Zhang X, Chen J, Cui Y, Cui Y, Yan G, Tang H, et al. A size-switchable microsphere loaded with salmon calcitonin as two-weekly dosing for osteoporosis therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2024;205:114565. doi:10.1016/j.ejpb.2024.114565
BibTeX
@article{Zhang2024,
author = {Zhang, Xueyan and Chen, Jicong and Cui, Yaxin and Cui, Yiying and Yan, Guodong and Tang, Haifeng and Man, Yuhong and Yang, Jie and Bi, Ye and Teng, Lesheng},
title = {A size-switchable microsphere loaded with salmon calcitonin as two-weekly dosing for osteoporosis therapy},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
volume = {205},
pages = {114565},
doi = {10.1016/j.ejpb.2024.114565}
}
EUVIMED